FH and nonpapillary renal cell carcinoma: While 3-bromopyruvate (3BrPA) selectively depletes ATP and induces apoptosis in ccRCC cells with intact mitochondrial defects, its efficacy is diminished in tumors with intact oxidative metabolism or FH mutations [96].